659 results on '"Du Pasquier, Renaud"'
Search Results
2. Increased central obesity correlates with physical activity and food processing in recently diagnosed multiple sclerosis
3. EBNA-1 and VCA-p18 immunoglobulin markers link Epstein-Barr virus immune response and brain’s myelin content to fatigue in a community-dwelling cohort
4. SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier
5. Central Vein Sign, Cortical Lesions, and Paramagnetic Rim Lesions for the Diagnostic and Prognostic Workup of Multiple Sclerosis
6. Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study
7. L’examen mimé objectif structuré (EMOS) : un outil innovant et apprécié pour enseigner l’examen et le raisonnement clinique neurologique
8. KIR3DL1 and Tox identify clonally expanded encephalitogenic neuron-specific CD8+ T cells in autoimmune encephalitis
9. Multiple Sklerose Therapie Konsensus Gruppe (MSTKG): Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose 2021 (White Paper)
10. Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5
11. Enlarged perivascular spaces are associated with brain microangiopathy and aging in multiple sclerosis.
12. Human stem cell derived neurons and astrocytes to detect auto-reactive IgG in neurological diseases
13. Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS
14. Neurologie: ce qui a changé en 2023
15. Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5
16. CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseasesʼ Treatments
17. The Swiss Brain Health Plan 2023–2033
18. Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation
19. Comprehensive proteomic analysis of JC polyomavirus-infected human astrocytes and their extracellular vesicles
20. Determination of nucleosidic/tidic reverse transcriptase inhibitors in plasma and cerebrospinal fluid by ultra-high-pressure liquid chromatography coupled with tandem mass spectrometry
21. Vaccine-associated measles in a patient treated with natalizumab: a case report
22. Vaccination in B-cell–depleted patients with multiple sclerosis
23. Clinical Reasoning: A 69-year-old man with rare complex visual symptoms
24. Retrospective comparison clinical presentation and outcome of Natalizumab and Fingolimod-associated PML (P7-3.004)
25. Chapter 6: Neuroinfectious Diseases
26. Unique proteomic signature of JCPyV-infected human astrocytes: from cells to extracellular vesicles
27. Tau Transfer via Extracellular Vesicles Disturbs the Astrocytic Mitochondrial System
28. Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF
29. One for all, all for one: neuro‐HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV
30. Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis
31. The Swiss Brain Health Plan 2023–2033
32. Natalizumab may control immune checkpoint inhibitor–induced limbic encephalitis
33. Pembrolizumab as a treatment for PML?: Waiting for Godot
34. Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis
35. Ocrelizumab Impairs the Phenotype and Function of Memory CD8+T Cells
36. Troubles cognitifs chez les personnes vivant avec le VIH. L’importance d’une prise en charge multidisciplinaire
37. Neurologie : ce qui a changé en 2022
38. Troubles cognitifs dans la sclérose en plaques : quand y penser ?
39. Cerebrospinal fluid HIV-1 escape in patients with neurocognitive symptoms: pooled data from a neuro-HIV platform and the NAMACO study
40. Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus
41. Generation of transgene-free human induced pluripotent stem cells from erythroblasts in feeder-free conditions
42. Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate
43. Late Lyme neuroborreliosis with chronic encephalomyelitis
44. Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine
45. Neurodegenerative phagocytes mediate synaptic stripping in Neuro-HIV
46. Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis
47. Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis
48. Long-Term Consequences of COVID-19: A 1-Year Analysis.
49. Ocrelizumab Impairs the Phenotype and Function of Memory CD8+ T Cells: A 1-Year Longitudinal Study in Patients With Multiple Sclerosis.
50. SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus Erythematosus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.